First Eagle Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-200
| Closed | -$4K | – | 271 |
|
|
2017
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 312 |
|
|
2017
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 331 |
|
|
2017
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 309 |
|
|
2017
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 305 |
|
|
2016
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 311 |
|
|
2016
Q3 | $9K | Hold |
200
| – | – | ﹤0.01% | 326 |
|
|
2016
Q2 | $10K | Sell |
200
-1,915,460
| -100% | -$95.8M | ﹤0.01% | 334 |
|
|
2016
Q1 | $103M | Sell |
1,915,660
-2,455,959
| -56% | -$131M | 0.26% | 99 |
|
|
2015
Q4 | $287M | Sell |
4,371,619
-95,392
| -2% | -$6.26M | 0.72% | 52 |
|
|
2015
Q3 | $252M | Buy |
4,467,011
+710,013
| +19% | +$40.1M | 0.64% | 53 |
|
|
2015
Q2 | $222M | Sell |
3,756,998
-448,483
| -11% | -$26.5M | 0.53% | 61 |
|
|
2015
Q1 | $262M | Buy |
4,205,481
+1,757,171
| +72% | +$109M | 0.62% | 53 |
|
|
2014
Q4 | $141M | Buy |
2,448,310
+1,027,730
| +72% | +$59.1M | 0.34% | 77 |
|
|
2014
Q3 | $76.4M | Buy |
1,420,580
+1,420,380
| +710,190% | +$76.3M | 0.19% | 100 |
|
|
2014
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 315 |
|
|
2014
Q1 | $11K | Hold |
200
| – | – | ﹤0.01% | 374 |
|
|
2013
Q4 | $8K | Hold |
200
| – | – | ﹤0.01% | 358 |
|
|
2013
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 343 |
|
|
2013
Q2 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 338 |
|